Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) research hub

A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter clinical trial to evaluate the efficacy and safety of linaprazan glurate compared to lansoprazole in maintenance of healing in participants with healed erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D

This study is testing a new medicine, linaprazan glurate, against an existing one, lansoprazole, to see how well they keep healed acid reflux (erosive esophagitis) from coming back. It involves adults with a history of this condition.